Probiotic VSL# 3 reduces liver disease severity and hospitalization in patients with cirrhosis: a randomized, controlled trial

RK Dhiman, B Rana, S Agrawal, A Garg, M Chopra… - Gastroenterology, 2014 - Elsevier
Background & Aims Little is known about whether probiotics can affect outcomes of patients
with cirrhosis and hepatic encephalopathy (HE). We assessed the efficacy of a probiotic …
被引用次数：368 相关文章

Probiotic VSL# 3 reduces liver disease severity and hospitalization in patients with cirrhosis: a randomized, controlled trial.

RK Dhiman, B Rana, S Agrawal, A Garg… - …, 2014 - europepmc.org
Methods We performed a double-blind trial at a tertiary care hospital in India. Patients with
cirrhosis who had recovered from an episode of HE during the previous month were …

Probiotic VSL# 3 Reduces Liver Disease Severity and Hospitalization in Patients With Cirrhosis: A Randomized, Controlled Trial

RK Dhiman, B Rana, S Agrawal, A Garg… - …, 2014 - gastrojournal.org
Background & Aims Little is known about whether probiotics can affect outcomes of patients
with cirrhosis and hepatic encephalopathy (HE). We assessed the efficacy of a probiotic …

Probiotic VSL# 3 reduces liver disease severity and hospitalization in patients with cirrhosis: a randomized, controlled trial

RK Dhiman, B Rana, S Agrawal, A Garg, M Chopra… - 2014 - pubmed.ncbi.nlm.nih.gov
Background & aims Little is known about whether probiotics can affect outcomes of patients
with cirrhosis and hepatic encephalopathy (HE). We assessed the efficacy of a probiotic …
[PDF] academia.edu

[PDF][PDF] Probiotic VSL# 3 Reduces Liver Disease Severity and Hospitalization in Patients With Cirrhosis: A Randomized, Controlled Trial

RK Dhiman, B Rana, S Agrawal, A Garg… - …, 2014 - academia.edu
BACKGROUND & AIMS: Little is known about whether probiotics can affect outcomes of
patients with cirrhosis and hepatic encephalopathy (HE). We assessed the efficacy of a …

Probiotic VSL# 3 Reduces Liver Disease Severity and Hospitalization in Patients With Cirrhosis: A Randomized, Controlled Trial

RK Dhiman, B Rana, S Agrawal, A Garg, M Chopra… - Gastroenterology, 2014 - infona.pl
Little is known about whether probiotics can affect outcomes of patients with cirrhosis and
hepatic encephalopathy (HE). We assessed the efficacy of a probiotic preparation in …

Probiotic VSL# 3 Reduces liver disease severity and hospitalization in patients with cirrhosis: a randomized, controlled trial.

RK Dhiman, BR Baldev Rana, SA Swastik Agrawal… - 2014 - cabidigitallibrary.org
Abstract Background & Aims: Little is known about whether probiotics can affect outcomes of
patients with cirrhosis and hepatic encephalopathy (HE). We assessed the efficacy of a …